Structural modelling of human complement FHR1 and two of its synthetic derivatives provides insight into their in-vivo functions
Human complement is the first line of defence against invading pathogens and is involved in tissue homeostasis. Complement-targeted therapies to treat several diseases caused by a dysregulated complement are highly desirable. Despite huge efforts invested in their development, only very few are curr...
Main Authors: | Natalia Ruiz-Molina, Juliana Parsons, Eva L. Decker, Ralf Reski |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037023000491 |
Similar Items
-
Functional and structural characterization of mouse Factor H-related B protein unveils a novel dimerization domain shared by FHR-B and FH
by: Adrián Martín-Ambrosio Doménech, et al.
Published: (2025-01-01) -
Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization
by: Éva Kárpáti, et al.
Published: (2020-07-01) -
Recombinant Production of MFHR1, A Novel Synthetic Multitarget Complement Inhibitor, in Moss Bioreactors
by: Oguz Top, et al.
Published: (2019-03-01) -
Atypical Hemolytic Uremic Syndrome-Associated FHR1 Isoform FHR1*B Enhances Complement Activation and Inflammation
by: Boyang Xu, et al.
Published: (2022-01-01) -
Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology
by: Luce Perie, et al.
Published: (2024-12-01)